TRKYY yields 6.77% · JNJ yields 2.13%● Live data
📍 TRKYY pulled ahead of the other in Year 1
Combined, TRKYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRKYY + JNJ for your $10,000?
Türkiye Sinai Kalkinma Bankasi A.S. operates as a development and investment bank in Turkey and internationally. The company engages in the industrial investments, energy and resource efficiency, environmental investments, renewable energy, sustainable tourism, women's employment and equal opportunity, occupational health and safety, investments in developing regions, education and health investments, R&D and innovation, and working capital financing activities. It also provides project finance for energy generation and power plants; electricity distribution and natural gas distribution projects; mergers and acquisitions; logistics, transportation, and telecommunications; and public - private partnership projects. In addition, the company offers wholesale banking and SME financing, foreign trade finance, working capital financing, and machinery and equipment leasing services; letter of guarantees/external guarantees/letter of credits; and export/Eximbank endorsement, and country loans. Further, it provides corporate finance products and services, such as public offering preparation and brokerage, debt instrument issues, and mergers and acquisitions advisory; derivatives products, such as forwards, options, caps and floors, swaps, and swaptions; repo, warrant, and foreign derivative transactions; securities loans; brokerage for stock and bonds trading; and portfolio management and investment advisory services. Additionally, the company offers financial planning strategy, feasibility, valuation, and restructuring services, as well as sectoral analysis studies; and engineering and technical advisory, real estate appraisal, economic research, and sustainability consultancy services. Türkiye Sinai Kalkinma Bankasi A.S. was incorporated in 1950 and is headquartered in Istanbul, Turkey.
Full TRKYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.